Journal
JOURNAL OF MEDICAL VIROLOGY
Volume 94, Issue 9, Pages 4216-4223Publisher
WILEY
DOI: 10.1002/jmv.27867
Keywords
anti-spike antibodies; breakthrough infection; Comirnaty (R) COVID-19 vaccine; neutralizing antibodies; nursing home residents; SARS-CoV-2 Omicron variant; spike-reactive T cells
Categories
Funding
- European Commission NextGenerationEU fund
- Instituto de Salud Carlos III
Ask authors/readers for more resources
This study investigated whether the levels of antibodies and T cells in peripheral blood after a booster dose of the Comirnaty (R) vaccine could predict breakthrough infections caused by the Omicron variant. The results showed that these immune parameters could not reliably predict the risk of contracting COVID-19 due to the Omicron variant in nursing home residents.
We investigated whether peripheral blood levels of SARS-CoV-2 Spike (5) receptor binding domain antibodies (anti-RBD), neutralizing antibodies (NtAb) targeting Omicron S, and S-reactive-interferon (IFN)-gamma-producing CD4(+) and CD8(+) T cells measured after a homologous booster dose (3D) with the Comirnaty (R) vaccine was associated with the likelihood of subsequent breakthrough infections due to the Omicron variant. An observational study including 146 nursing home residents (median age, 80 years; range, 66-99; 109 female) evaluated for an immunological response after 3D (at a median of 16 days). Anti-RBD total antibodies were measured by chemiluminescent immunoassay. NtAb were quantified by an Omicron S pseudotyped virus neutralization assay. SARS-CoV-2-S specific-IFN gamma-producing CD4(+) and CD8(+) T cells were enumerated by whole-blood flow cytometry for intracellular cytokine staining. In total, 33/146 participants contracted breakthrough Omicron infection (symptomatic in 30/33) within 4 months after 3D. Anti-RBD antibody levels were comparable in infected and uninfected participants (21 123 vs. 24 723 BAU/ml; p = 0.34). Likewise, NtAb titers (reciprocal IC50 titer, 157 vs. 95; p = 0.32) and frequency of virus-reactive CD4(+) (p = 0.82) and CD8(+) (p = 0.91) T cells were similar across participants in both groups. anti-RBD antibody levels and NtAb titers estimated at around the time of infection were also comparable (3445 vs. 4345 BAU/ml; p = 0.59 and 188.5 vs. 88.9; p = 0.70, respectively). Having detectable NtAb against Omicron or SARS-CoV-2-S-reactive-IFN gamma-producing CD4(+) or CD8(+) T cells after 3D was not correlated with increased protection from breakthrough infection (OR, 1.50; p = 0.54; OR, 0.0; p = 0.99 and OR 3.70; p = 0.23, respectively). None of the immune parameters evaluated herein, including NtAb titers against the Omicron variant, may reliably predict at the individual level the risk of contracting COVID-19 due to the Omicron variant in nursing home residents.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available